Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

NCT ID: NCT03818620

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-07

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter prospective observational clinical investigation with a medical device. The purpose of this study is to develop and validate of a new type of digital dermatoscope with automatic decision support algorithms. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Cancer Skin Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Barco digital dermatoscope device images

Images of skin lesion taken with the Barco dermatoscope by site team member

Intervention Type DEVICE

Reference standard dermatoscope device images

Images of skin lesion taken with a standard dermatoscope device (as part of standard care)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient has a lesion that is accessible to the Barco Digital Dermatoscope
* Patient gives informed consent
* Men or women of any ethnic group aged ≥ 18 years

Exclusion Criteria

* Men or women of any ethnic group aged \< 18 years
* Patients not willing or able to read, understand and sign the study-specific informed consent form
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Barco NV

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marjan Garmyn, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

UZ / KU Leuven

Lieve Brochez, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

UZ Gent

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Gent

Ghent, , Belgium

Site Status

UZ / KU Leuven

Leuven, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B322201732457

Identifier Type: OTHER

Identifier Source: secondary_id

80M0675

Identifier Type: OTHER

Identifier Source: secondary_id

CI-PROT-0010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MoleGazer Development Feasibility Study
NCT05015816 ACTIVE_NOT_RECRUITING NA